Table:
begin	end	state
1	92	cytoplasmic
93	110	transmembrane
111	129	non-cytoplasmic
130	152	transmembrane
153	174	cytoplasmic
175	193	transmembrane
194	204	non-cytoplasmic
205	224	transmembrane
225	228	cytoplasmic
229	248	transmembrane
249	256	non-cytoplasmic
257	279	transmembrane
280	286	cytoplasmic
287	304	transmembrane
305	340	non-cytoplasmic
341	359	transmembrane
360	389	cytoplasmic
390	409	transmembrane
410	421	non-cytoplasmic
422	453	transmembrane
454	464	cytoplasmic
465	483	transmembrane
484	515	non-cytoplasmic

Input:
>WP_041938756.1 NCBI__GCF_000058485.1:WP_041938756.1
MSTPPPAGPPGPPDPAGPGSGAATMPLRVAGSRSGPSGSAAPGASADSLARADPLAPADP
VGHGGPSGPGPGGGPGLPAWHPAVLFAPARLRQLGALLLVGVLAAIVTGPTGNSDKPLQA
AKDSIVDVRIVLYLGLAAALWVLLVLGAELRGALERLSAPVRAPIGAAYGRRGGPIVLNL
VLLAVAILAPLVVSTAAQQSMVNDIGIYALLALGLNVVVGYAGLLDLGYIAFFAIGAYAT
AYFTSQTAMPWHAPFVLNPFFVFPIALVLAALAGVILGAPTLRLRGDYLAIVTLGFGEII
HLVANNADGITNGARGAFGVPHLSIDLLGIDYKWGIDPLPYYYLLLAIVIGVMIAFGRLE
RSRIGRSWAAIREDEIAAEATGVATLRMKLLAFAIGASVSGFAGVLFASKQFFNPQSFSL
QASFFVVAVVIFGGMGSRLGVVVGAVVLQGLAFYLRDKVQPADRYIYFGAVIVIMMIFRP
QGLVPSRRRRREIELAEEGIGAADSLGAAPTGGHR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server